Find link

language:

jump to random article

Find link is a tool written by Edward Betts.

searching for Tesaro 7 found (111 total)

alternate case: tesaro

Dostarlimab (242 words) [view diff] exact match in snippet view article find links to article

undergoing Phase I, Phase II, and Phase III clinical trials. The manufacturer, Tesaro, announced prelimary successful results from the Phase I/II GARNET study
EUCOPE (363 words) [view diff] exact match in snippet view article find links to article
Orphan Europe, Ovid, Prothena, PTC, Santhera, Santen, Sarepta, Sobi, Takeda, Tesaro, Vertex, Vifor Pharma, Zealand Pharma and Zogenix. EUCOPE, inter alia, represents
OPKO Health (389 words) [view diff] exact match in snippet view article find links to article
developed Varubi, a chemotherapy inducted nausea medication out-licensed to Tesaro and TerSera Therapeutics The Chairman and CEO of OPKO is Dr. Phillip Frost
PARP inhibitor (1,589 words) [view diff] exact match in snippet view article find links to article
medpagetoday.com. 19 December 2016. Zejula FDA Professional Drug Information. "Tesaro earns CHMP thumbs-up for Zejula as three-way PARP race heats up | FiercePharma"
HAVCR2 (1,845 words) [view diff] exact match in snippet view article find links to article
(LY3321367, Eli Lilly and Company; MBG453, Novartis Pharmaceuticals; TSR-022, Tesaro, Inc.) in combination with anti-PD-1 or anti-PD-L1 therapies are ongoing
LAG3 (6,164 words) [view diff] exact match in snippet view article find links to article
the Treatment of Solid Tumors" at ClinicalTrials.gov "Tesaro's Immuno-Oncology Platform". Tesaro web site. "Technology Platforms". Immutep LAG-3. Archived
Institute for Clinical and Economic Review (1,035 words) [view diff] exact match in snippet view article find links to article
25 June 2019. "Cancer-fighting PARP drugs from AstraZeneca, Clovis and Tesaro largely overpriced, watchdog says". FiercePharma.com. Retrieved 25 June